InMed Pharmaceuticals (INM)
(Delayed Data from NSDQ)
$0.27 USD
-0.02 (-6.41%)
Updated Jul 29, 2024 03:59 PM ET
After-Market: $0.27 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
InMed Pharmaceuticals Inc. [INM]
Reports for Purchase
Showing records 21 - 31 ( 31 total )
Company: InMed Pharmaceuticals Inc.
Industry: Medical - Drugs
Company: InMed Pharmaceuticals Inc.
Industry: Medical - Drugs
Company: InMed Pharmaceuticals Inc.
Industry: Medical - Drugs
Company: InMed Pharmaceuticals Inc.
Industry: Medical - Drugs
Company: InMed Pharmaceuticals Inc.
Industry: Medical - Drugs
Company: InMed Pharmaceuticals Inc.
Industry: Medical - Drugs
Phase II enrolment to begin in second half
Provider: Edison Investment Research Limited
Analyst: JACOBS M
Company: InMed Pharmaceuticals Inc.
Industry: Medical - Drugs
Company: InMed Pharmaceuticals Inc.
Industry: Medical - Drugs
Company: InMed Pharmaceuticals Inc.
Industry: Medical - Drugs
Company: InMed Pharmaceuticals Inc.
Industry: Medical - Drugs
Company: InMed Pharmaceuticals Inc.
Industry: Medical - Drugs
INM-755 Phase I complete, on to Phase II
Provider: Edison Investment Research Limited
Analyst: JACOBS M